MENU
+Compare
XAIR
Stock ticker: NASDAQ
AS OF
Dec 26, 12:40 PM (EDT)
Price
$0.47
Change
+$0.05 (+11.90%)
Capitalization
79.87M

XAIR Beyond Air Forecast, Technical & Fundamental Analysis

a medical device company, which engages in the development of nitric oxide (NO) generator and delivery system.

XAIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for XAIR with price predictions
Dec 24, 2024

XAIR in upward trend: price may ascend as a result of having broken its lower Bollinger Band on December 18, 2024

XAIR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 38 cases where XAIR's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where XAIR advanced for three days, in of 249 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 89 cases where XAIR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for XAIR moved out of overbought territory on November 27, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 similar instances where the indicator moved out of overbought territory. In of the 23 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on December 06, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on XAIR as a result. In of 103 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for XAIR turned negative on December 02, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .

XAIR moved below its 50-day moving average on December 16, 2024 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for XAIR crossed bearishly below the 50-day moving average on December 20, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XAIR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.484) is normal, around the industry mean (23.300). P/E Ratio (0.000) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (71.942) is also within normal values, averaging (43.338).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. XAIR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XAIR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
XAIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

XAIR is expected to report earnings to fall 45.00% to -15 cents per share on February 06

Beyond Air XAIR Stock Earnings Reports
Q4'24
Est.
$-0.15
Q3'24
Est.
$-0.28
Q2'24
Beat
by $0.07
Q1'24
Missed
by $1.33
Q4'23
Beat
by $0.04
The last earnings report on November 11 showed earnings per share of -28 cents, meeting the estimate of -28 cents. With 202.45K shares outstanding, the current market capitalization sits at 79.87M.
A.I. Advisor
published General Information

General Information

a medical device company, which engages in the development of nitric oxide (NO) generator and delivery system.

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
900 Stewart Avenue
Phone
+1 516 665-8200
Employees
98
Web
https://www.beyondair.net
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SID1.500.03
+2.04%
Companhia Siderurgica Nacional SA
BLUE7.790.13
+1.70%
bluebird bio Inc
NNN40.710.26
+0.64%
NNN Reit
CVX143.840.87
+0.61%
Chevron Corp
SWIM6.950.02
+0.29%
Latham Group

XAIR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, XAIR has been loosely correlated with OPK. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if XAIR jumps, then OPK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XAIR
1D Price
Change %
XAIR100%
-4.53%
OPK - XAIR
35%
Loosely correlated
N/A
KIDS - XAIR
32%
Poorly correlated
-0.20%
SHWGY - XAIR
32%
Poorly correlated
N/A
CERS - XAIR
31%
Poorly correlated
N/A
IDXX - XAIR
31%
Poorly correlated
+0.11%
More